Inclusion Criteria:  Patient who have signed informed consent. Consecutive retrospective patients and prospective patients treated with new clinical practice oncological treatments (approved by AIFA) from January 2012 to February 2024 Male or female, age ≥18 years.  Exclusion Criteria:  Participation in another clinical trial with any investigational drug.